AKT; Amyloid precursor protein; Apoptosis; Cell adhesion; Cytoprotection; Staurosporine; UV-B sAPPa, the soluble form of the b-amyloid precursor protein, has been shown to act as a potent epidermal growth factor by stimulating keratinocyte proliferation and migration. In this report we provide evidence for a cytoprotective role of sAPPa. As a model we used HaCaT cells and normal human keratinocytes (NHK) cultured in the absence of fetal calf serum and bovine pituitary extract. Under these conditions keratinocytes began to undergo apoptosis at increasing rates after 96 h of culture. Surprisingly, keratinocytes were protected from apoptosis by the addition of 50 nM recombinant sAPPa. Subsequent experiments were performed to elucidate the regulatory basis of the cytoprotective role of sAPPa. We found that recombinant sAPPa facilitated the substrate adhesion of keratinocytes in the first 30 minutes after seeding. The basis for this adhesion-promoting function was shown by the ability of recombinant sAPPa to continuously coat the culture dish thereby promoting the ability to bind keratinocytes. A second mechanism explaining the cytoprotective role was found in the significant inhibition of apoptosis by recombinant sAPPa. In HaCaT cells moderate UV-B irradiation was sufficient to induce apoptosis. In contrast, induction of apoptosis in NHK required additionally the depletion of endogenous sAPPa suggesting that sAPPa mediates protection against UV-B irradiation. Staurosporine-induced apoptosis rates were significantly reduced by about 59% after addition of recombinant sAPPa. These results show that sAPPa exerts a pronounced cytoprotective effect and that this effect is mediated by facilitated cell adhesion and by the antiapoptotic function of sAPPa.
Introduction
The human epidermis represents the largest organ of the human organism covering an area of about 1.8 m 2 and forms the outer barrier, protecting the organism against a large variety of physical, chemical and microbiological disturbances and other possible environmental impairments (Holbrook, 1994) . This protective role is accomplished by a series of cooperating mechanisms which involve the constant renewal of the epidermis through proliferation of keratinocytes and shedding (Jones et al., 1985) , cornified envelope formation (Kalinin et al., 2002) and the epidermal resilience against physical stress through the specific cytoskeleton of keratinocytes (Cowin and Burke, 1996) as well as the characteristic cell-cell (Braga, 2002) and cellmatrix interactions (Jamora and Fuchs, 2002; Madison, 2003) . Important regulatory roles in these functions are facilitated by ions, cytokines and growth factors (Fuchs and Raghavan, 2002; Werner and Grose, 2003) . Epidermal growth factor (EGF) (Nanney et al., 1996) derived from platelets, transforming growth factor-a (TGF-a) from basal keratinocytes (Nanney et al., 1996; Rappolee et al., 1988) , keratinocyte growth factor (KGF) from dermal fibroblasts (Werner et al., 1992) , and activin (Grose and Werner, 2002; Munz et al., 1999) are key regulators of central epidermal functions. More recently sAPPa, the soluble N-terminal form of the amyloid precursor protein (APP), has been described as a new epidermal growth factor due to its mitogenic (Hoffmann et al., 2000; Saitoh et al., 1989; Siemes et al., 2004) and motogenic (Kirfel et al., 2002) activities.
Some growth factors have been shown to exert in addition to these functions a cytoprotective effect. Thus, KGF has been identified as a potent survival factor for keratinocytes (Auf dem Keller et al., 2004) and for different types of other epithelial cells (Werner, 1998) , e.g. lung epithelial cells, which are protected from hyperoxide-induced cell death in the presence of this growth factor (Ray et al., 2003) . These effects can be studied in vivo and in vitro. For in vitro studies, numerous keratinocyte culture techniques have been developed that usually imply either the application of highly supplemented fibroblast-conditioned media (Rheinwald and Green, 1975) or the addition of animal-derived materials such as serum albumin (BSA), transferrin, insulin, fetal calf serum (FCS) and bovine pituitary extract (BPE) (Shipley and Pittelkow, 1987) . When these in part ill-defined factors are absent, keratinocytes are unable to perform continuous growth and subculture. Such conditions, however, are useful to analyze growth factor functions and their possible cytoprotective role.
In this report we show that recombinant sAPPa exerts cytoprotective effects on keratinocytes when cultured in the absence of FCS and EGF/BPE. The protective effect of recombinant sAPPa appears to be mediated by cell adhesion and by inhibition of apoptosis. These results are likewise of interest for understanding the biological role of sAPPa as an epidermal growth factor as well as for the maintenance of human keratinocytes in culture for prolonged periods of time in the absence of complex culture media constituents.
Materials and methods

Material, tissues and cells
HaCaT cells (human adult low calcium, high temperature keratinocytes) (Boukamp et al., 1988) were provided by Dr. N. E. Fusenig (German Cancer Research Center, Heidelberg, Germany), keratinocytes from normal human breast skin were from dissociation of freshly isolated epidermis. Human skin from surgically removed female breast was kindly provided by Dr. K. Jaeger (Marienhospital, Br¸hl, Germany) . Experimentation with human tissue samples was conducted according to the ethical principles and guidelines of the Medical Faculty of the University of Bonn as approved by the governmental authorities. Dulbecco×s minimal essential medium (DMEM), keratinocyte growth medium (KGM), trypsin/EDTA solution and soybean trypsin inhibitor were purchased from Cambrex (Verviers, Belgium). The primary monoclonal mouse anti-sAPPa antibody 1560 (binding at the amino acid residues 1 ± 17 of the b-amyloid protein sequence) was from Chemicon International (Hofheim, Germany), the monoclonal antisAPPa antibody 6E10 was purchased from Senetek Inc. (St. Louis, MO, USA) and the monoclonal anti-actin antibody (clone C4) was from ICN (Eschwege, Germany). The primary polyclonal anti-PARP antibody #9542, polyclonal anti-phospho-AKT (Ser473) antibody #9271S and polyclonal anti-AKT antibody #9272 were purchased from CellSignaling (New England Biolabs; Frankfurt am Main, Germany). The secondary 5-(4,6-dichlorothiazin-2-yl)-amino-fluorescein hydrochloride (DTAF), gold-or peroxidase-labeled anti-mouse or anti-rabbit antibodies were from Dianova (Hamburg, Germany).
Cell culture
HaCaT cells were cultured at 37 8C and with 10% CO 2 in DMEM (Cambrex) containing 10% fetal calf serum (FCS). Cells were passaged every ten days in a 1 : 10 ratio by incubation with 0.53 mM EDTA in phosphate-buffered saline (PBS) for 10 minutes followed by the treatment with 0.05% trypsin (0.5 mg/ml containing 0.5 mg/ml EDTA in PBS; Cambrex) for 5 minutes. Normal human keratinocytes (NHK) were obtained from freshly prepared human epidermis. For separation of basal cells, the epidermis was dissociated with 0.05% trypsin for 6 minutes at 37 8C. The cells were dispersed by pipetting, washed in KGM containing 0.5 mg/ml trypsin inhibitor (Cambrex), separated from the fragments by filtration with a cell strainer (70 mm pore size Nylon gauze; Becton Dickinson Labware, Heidelberg, Germany) and suspended in freshly prepared medium. NHK were cultured in serum-free KGM containing 20 mM CaCl 2 , 100 pg/ml epidermal growth factor (EGF), 5 mg/ml insulin, 500 ng/ml hydrocortisone, 0.4% (v/v) bovine pituitary extract (BPE) and 0.1% gentamicin sulfate/amphotericin B. In all studies, the cells were washed twice with KGM without FCS and EGF/BPE or DMEM without FCS and cultured during the experiments in EGF/BPE-and FCS-free medium.
Preparation of recombinant sAPPa
RNA was isolated from human brain tissue and RNA of the isoforms APP 751 and 770 was reverse-transcribed. The resulting cDNA was amplified by PCR using a primer encoding a His-tag at the N-terminus. The sAPPa isoform was expressed in EBNA293 cells (Invitrogen, Groningen, The Netherlands) and cultured in serum-free DMEM, using the episomal pCEP4 expression vector system (Invitrogen) which included the signal peptide sequence from SPARC (osteonectin), a 32-kDa secreted matrix-glycoprotein obtained from Dr. Rupert Timpl (Max-Planck-Institute for Biochemistry, Martinsried, Germany). The supernatants of cells were collected and His-tagged sAPPa was purified using Talon TM metal affinity chromatography (Clontech, Heidelberg, Germany). The bound His-tagged isoform (see Fig. 3c ) was eluted by the application of a pH shift (50 mM Na 2 HPO 4 , pH 5.0, in 300 mM NaCl) as described (Pietrzik et al., 1998) and fractions were tested for purity by Coomassie staining of SDS-polyacrylamide gels and gel-chromatography using standard procedures. The fractions with highest degree of purity showing only a single band in SDS-PAGE were combined and dialyzed overnight against PBS prior to use.
Cell adhesion assay
For the analysis of cell-substrate adhesion, keratinocytes were seeded at a density of 1 Â 10 5 cells per well in a 12-well tissue culture plate (TPP Tissue Culture Labware, Trasadingen, CH), each well containing a final volume of 500 ml KGM without FCS and EGF/BPE (KGM À ) or DMEM without FCS (DMEM À ). After incubation at 37 8C for the indicated times, the plates were swirled three times and the media with the unattached keratinocytes were collected. The number of cells was determined using a B¸rker counting chamber (Marienfeld GmbH, Laboratory Glassware, Lauda-Kˆnigshofen, Germany). At each time point double samples were assayed and each experiment was repeated three times.
Cell growth assay and live-cell imaging microscopy
The observations on cell growth were made by live-cell imaging microscopy, a method allowing to take micrographs under optimal culture conditions over prolonged periods of time for up to 168 hours. To detect all changes in the number of cells from the same area, keratinocytes were seeded at a density of 2 Â 10 4 cells on CELLocate coverslips (Eppendorf-Netheler-Hinz GmbH, Hamburg). These coverslips have a micro-grid structure on their surface containing 40 numbered fields each with 24 squares. After 24 hours the first micrograph (0 h) was taken and the culture medium with FCS and EGF/BPE was changed to DMEM À , to DMEM À with 50 nM recombinant sAPPa or to KGM À as well as KGM À with 50 nM recombinant sAPPa. Micrographs of identical areas of the coverslips were taken every 24 hours.
Coating coverslips with recombinant sAPPa
Glass coverslips (15 Â 15 mm 2 ) were washed and sterilized by incubation in ethanol and acetone followed by treatment with 100 ml DMEM À containing 50 nM recombinant sAPPa for 30 minutes at 37 8C. After incubation the coated coverslips were washed twice with DMEM À .
Immunocytochemical detection of recombinant sAPPa coating
The coated coverslips were fixed with 4% paraformaldehyde in PBS for 30 minutes and blocked with 3% BSA in PBS for 60 minutes at room temperature. The coating with recombinant sAPPa was visualized by incubation of the coverslips with the mouse anti-sAPPa antibody 1560 for 15 hours at 4 8C. For immunofluorescence the coverslips were incubated with DTAF-labeled goat anti-mouse IgG for 60 minutes at 37 8C. After washing in PBS three times for 5 minutes and once with water, the coverslips were mounted with anti-fade reagent (Biomeda Corp., Foster City, CA, USA) and viewed with a confocal laser scanning microscope (LSM 510, Zeiss, Jena, Germany).
For scanning electron microscopy the coverslips were incubated for 60 minutes with a secondary gold-labeled (12 nm diameter) goat antimouse IgG antibody. After the incubation the coverslips were prepared for scanning electron microscopy as described below.
Scanning electron microscopy (SEM)
Coverslips were fixed in 2% glutaraldehyde and 4% paraformaldehyde in PBS for 25 minutes. After rinsing with distilled water, specimens were dehydrated in ethanol and critical point dried from CO 2 in 10 cycles using a Balzers CPD030 (BAL-TEC, Schalksm¸hlen, Germany). Dried specimens were mounted on aluminum holders and sputter-coated with 2 nm platinum/palladium in an HR208 coating device (Cressington, Watford, UK). Scanning electron microscopy was performed at 3 kV using an XL30 SFEG (FEI, Eindhoven, The Netherlands) equipped with a through-lens secondary electron detector.
Induction of apoptosis in keratinocytes
Subconfluent cultures of HaCaT cells or NHK were maintained for 24 hours in DMEM À and treated with 1 mM staurosporine for 5 hours. Induction of apoptosis with 30 mJ/cm 2 by UV-B was performed using a UV-B crosslinker (Techne, Duxford, UK). Some cultures were supplemented with the sAPPa-binding antibody 6E10 (2 ml/ml culture medium) 30 minutes before UV-B irradiation. For UV-B irradiation the culture media were replaced by 200 ml (for 60 mm culture dishes) PBS (37 8C). After irradiation the PBS was replaced again by culture medium and cells were cultured for another 18 hours prior to use.
PARP cleavage assay
HaCaTand NHK cells were scraped off with a cell scraper (Sarstedt Inc., Newton, NC, USA) in the culture medium, centrifuged at 300 g for 5 minutes, washed once with ice-cold PBS and lysed for 20 minutes on ice in lysis buffer (5 volumes of cell pellet; 20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5% NP40, 2.5 mM sodium pyrophosphate, 1 mM b-glycerolphosphate, 1 mM Na2 VO 4 , 1 mg/ml leupeptin and 1 mM PMSF). After lysis, samples were sonicated for 15 seconds and centrifuged for 10 minutes at 15,000 g. Protein concentration of the supernatant was measured using DC Protein Assay (Biorad, Munich, Germany). Fifteen mg total protein were separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane. For the detection of PARP the polyclonal anti-PARP antibody was used. The immunoblot was quantitatively assessed by using the Scion Image Software (Scion Inc.; Maryland, USA).
Caspase-3 activation assay
HaCaT cells were scraped off with a cell scraper, centrifuged at 300 g for 5 minutes, washed once with ice-cold PBS and analyzed for caspase-3 activity with the caspase-3 assay kit (Sigma, Taufkirchen, Germany) according to the manufacturer×s instructions. Briefly, cells were lysed for 15 ± 20 minutes in HEPES lysis buffer and centrifuged for 10 minutes at 15,000 g. The supernatants were mixed with the reaction buffer containing the specific caspase-3 substrate Ac-DEVD-AMC. After incubation at 37 8C for 1.5 hours the fluorescence was measured two times at 360 nm excitation and 460 nm emission.
AKT activation assay
Subconfluent cultures of HaCaT cells were serum-starved for 24 hours in DMEM. Cells were stimulated with fresh medium containing 10 nM recombinant sAPPa, 10% FCS or 50 nM recombinant EGF for the indicated times. After stimulation, cells were washed with ice-cold PBS, scraped off with a cell scraper, spun down at 300 g for 5 minutes and lysed on ice for 20 minutes in lysis buffer (see PARP cleavage section) followed by a 15-second sonification. Supernatants of centrifuged samples were separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane. Detection of AKT activation was performed using the anti-Phospho-AKT Ser473 antibody and protein loading was monitored by anti-AKT antibody.
Statistical analysis
The results were analysed for statistical differences between the groups by a one way analysis of variance (one way ANOVA). In general, the differences were taken to be statistically significant at P < 0.05.
Results
Growth factor function of recombinant sAPPa in keratinocyte culture medium
In this study, the relevance of recombinant sAPPa as a growth factor supplement in culture media was analysed to determine its protective function on human keratinocytes. Previous studies have shown that sAPPa is involved in the growth and differentiation processes of keratinocytes and that the addition of recombinant sAPPa to the culture medium of keratinocytes results in a significant increase in the rates of proliferation (Hoffmann et al., 2000; Siemes et al., 2004) and migration (Kirfel et al., 2002) .
The number of keratinocytes was determined after 24, 48, 72, 96, 120, 144 and 168 hours under optimal culture conditions (37 8C, 5% CO 2 humidity) using live-cell imaging microscopy. The quantitation of the micrographs (Fig. 1a, b) revealed that the growth of keratinocytes in KGM without FCS and EGF/ BPE (KGM À ) decreased initially by about 15%. After 96 hours a pronounced further decrease in the cell number was observed and after 168 hours almost 70% of the keratinocytes detached and underwent cell death. This cell death showed major morphological criteria of apoptosis, i.e. rounding and condensation of cells as indicated by their smaller size, loss of cell-cell contacts and increased light absorption (Fig. 1a) .
In contrast, the addition of 50 nM recombinant sAPPa in KGM À resulted in a significantly increased keratinocyte growth by 20% for 48 hours, indicating the growth factor function of recombinant sAPPa (Hoffmann et al., 2000; Siemes et al., 2004) . The protective effect of recombinant sAPPa became apparent after 96 hours of incubation. Compared to the strong decline of the cell number in KGM À , the keratinocytes in KGM À in the presence of recombinant sAPPa showed only a minor decrease thereafter remaining constant for at least 168 hours.
Recombinant sAPPa as an adhesion factor
To determine the ability of recombinant sAPPa to enforce keratinocyte adhesion, HaCaT cells were seeded at a density of 1 Â 10 5 cells per well in 500 ml DMEM without FCS (DMEM À ) in the presence or absence of 50 nM recombinant sAPPa. After the indicated incubation time (30, 60, 120, 180, and 240 minutes) the number of the non-adherent cells in the supernatant was determined. Based on the total cell number seeded it was possible to conclude at each time point on the number of adherent cells. A significant increase in the adhesion rate (50%) of HaCaT cells in DMEM À with 50 nM recombinant sAPPa compared to cells grown in DMEM À was detectable after 30 minutes (Fig. 2, arrow) . After 240 minutes of culture in the respective medium the number of non-adherent cells reached almost identical levels.
A possible reason for the fast and efficient adhesion of keratinocytes in the presence of sAPPa might have been the coating of culture dishes or coverslip surfaces. To analyse this, culture dishes or coverslips were partially covered with medium containing 50 nM recombinant sAPPa. Immunofluorescence (Fig. 3a) and immunogold (Fig. 3b ) labeling revealed that a continuous layer of recombinant sAPPa is formed on the glass surfaces.
The antiapoptotic effect of sAPPa
To investigate whether the cytoprotective function of sAPPa is mediated by an antiapoptotic effect we induced apoptosis by two different stimuli in NHK and HaCaT cells in the presence or absence of sAPPa. Serum-starved NHK and HaCaT cells were irradiated with 30 mJ/cm 2 UV-B in the presence or absence of the sAPPa-binding antibody 6E10 for 18 hours. The amount of antibody that is sufficient to bind all sAPPa secreted by the cells during 24 hours, was determined by immunoprecipitation experiments in comparison to the N-terminal mapping antibody (AB 1560) against sAPPa (results not shown). Figure 4 shows, that UV-B irradiation led to cleavage of the apoptotic marker protein PARP in HaCaT cells. Depletion of cell-secreted sAPPa by the 6E10 antibody strongly increased the UV-B-induced PARP cleavage. In NHK cells PARP cleavage was not induced by UV-B irradiation alone. However, in the presence of 6E10 antibody, strong UV-B induced PARP cleavage was detected. In a more direct approach we examined whether the exogenous addition of recombinant sAPPa exerts an antiapoptotic effect. For this purpose, apoptosis was induced in HaCaT cells by the protein kinase C inhibitor staurosporine in the presence or absence of recombinant sAPPa. The rates of apoptosis were quantified by the casapse-3 activation assay. Staurosporine treatment induced the activation of caspase-3 that could be inhibited by a caspase-3-specific inhibitor, indicating the specificity of the detection method (Fig. 5) . In Fig. 2 . Accelerated adhesion of keratinocytes in the presence of recombinant sAPPa. When HaCaT cells were cultured in DMEM without FCS (DMEM À ) but supplemented with 50 nM recombinant sAPPa keratinocytes became rapidly adherent within the first 30 minutes after seeding. HaCaT cells seeded in the absence of recombinant sAPPa showed a delayed adhesion, which began between 30 and 60 minutes after seeding. (n 3; * significant vs. DMEM À recombinant sAPPa; p < 0.05) Fig. 3 . Coating of surfaces with recombinant sAPPa for cell culture. Coverslips, partially taped for control purposes, were coated for 30 minutes with recombinant sAPPa. Immunofluorescence (a) and immunogold scanning electron (b) microscopy revealed a continuous coating with recombinant sAPPa. The taped areas used as controls remained free of any marker. (c) Structure of recombinant sAPPa carrying a His-tag for purification purposes. The scheme depicts also the distribution of the three heparin-binding sites (HBS), the Kunitztype serine proteinase inhibitor domain by which it is distinguished from sAPP 695 (KPI) and the putative proliferation-stimulatory region (Jin et al., 1994 ) (light-gray box, partly overlapping with the middle HBS). (Bar in a, 100 mm; in b, 500 nm) the presence of recombinant sAPPa, the staurosporine-induced caspase-3 activation (100%) was reduced by about 59% (Fig. 5) .
The question arose whether the cytoprotective effect of sAPPa was mediated by the activation of protein kinase B (AKT), a central regulator of the main antiapoptotic signaling pathway. For this purpose, we stimulated HaCaT cells for up to 15 minutes with recombinant sAPPa, EGF or FCS and analyzed the cell lysates for phosphorylation of protein kinase B (AKT). Figure 6 shows, that recombinant sAPPa induced a phosphorylation of AKT comparable to the levels obtained with EGF and FCS.
Discussion
Cytoprotection in the epidermis is an important means to avoid cell death, e.g. in the basal keratinocyte layer following irradiation by UV light (Teraki and Shiohara, 1999) . In vitro, cell death is observed when major constituents of the culture medium are lacking. As yet, only for KGF a cytoprotective effect in keratinocytes has been demonstrated (for review see (Werner, 1998) ). Apparently, poorly defined supplements to the culture medium such as FCS or EGF/BPE contain KGFand other factors, which exert cytoprotective functions as well. FCS is also known to contain sAPPa which is a normal constituent of the blood where it is thought to derive from circulating platelets (Bush et al., 1993) . Our observations with keratinocytes cultured in the absence of FCS and EGF/BPE indicate that recombinant sAPPa as a supplement in culture media plays a cytoprotective role. The results are of interest for understanding the growth factor function of sAPPa and might be useful for the definition of culture conditions that require cytoprotection of keratinocytes.
Cytoprotective effects of sAPPa
The overall structure suggests that sAPPa functions as a growth factor (Rossjohn et al., 1999) . Indeed, sAPPa has been shown to operate in cell proliferation, e.g. in APP-deficient fibroblasts , and in neurite outgrowth (Milward et al., 1992; Perez et al., 1997) . We have previously shown that sAPPa binds to cell surfaces with high affinity, resulting in the induction of cell proliferation by MAP kinase in thyrocytes or keratinocytes (Hoffmann et al., 2000; Pietrzik et al., 1998) and of cell migration (Kirfel et al., 2002) . In skin wounds the expression of APP in keratinocytes and the release of sAPPa in in vitro wound healing models are increased suggesting a role of sAPPa in epidermal wound repair (Kummer et al., 2002) .
NHK or HaCaT cells proliferate continuously at high rates when cultured in KGM containing FCS and EGF/BPE whereas in the absence of FCS and EGF/BPE the cells begin to undergo cell death with a significant increase after 96 h of culture. This cell death exerts major morphological signs of apoptosis. Keratinocytes are protected from this apoptosis, however, when this minimal medium is supplemented with sAPPa. This cytoprotection continues for prolonged periods of time, and cells are maintained under these conditions in a state of proliferation competence (unpublished observation). Cytoprotection has been described before to occur in neurons in the presence of sAPPa (Mattson, 1997) suggesting that this effect of sAPPa may be a more general phenomenon and not restricted to special cell types. It remained, however, unclear by which mechanism the cytoprotective effect of sAPPa is achieved. Possible clues for understanding the underlying mechanisms came from two observations, first on the function of sAPPa in cell adhesion and second on its antiapoptotic effects.
sAPPa facilitates cell adhesion
Keratinocytes of the basal layer adhere to the basement membrane through hemidesmosomes and focal contacts by adhesive proteins of the integrin family. Whereas the transmembrane components of the hemidesmosomes are formed by the a6b4 class of integrin heterodimers (Sonnenberg et al., 1991) , the a3b1 integrin heterodimer forms focal contacts (Watt, 2002) . Both keratinocyte-matrix contacts play an important role in keratinocyte migration (reviewed by Kirfel et al. (2004) ), as well as in cell proliferation and differentiation (Adams and Watt, 1990; Watt et al., 1993) .
APP and sAPPa are also known to be involved in cell adhesion through the presence of special domains for binding heparin (Mattson, 1997) , collagen (Beher et al., 1996) and integrin (Narindrasorasak et al., 1992) . Increased expression of APP in neural B103 cells has been shown to result in increased adhesion of cells to collagen type IV substrates (Schubert and Behl, 1993) .
The results shown here indicate that recombinant sAPPa significantly mediates and increases keratinocyte adhesion about 50-fold. This effect is detectable only during the first 30 min of culture after seeding. It has been shown before that at longer periods of culture keratinocytes release accumulating quantities of endogenous sAPPa (Hoffmann et al., 2000) which are apparently sufficient to mediate keratinocyte adhesion to the culture dish.
The enhancement of adhesion allows keratinocytes to maintain their proliferation competence whereas non-adherent cells may enter a differentiation program which eventually leads to cell death (Skerrow, 1978) . As shown in this study, this process is delayed by sAPPa when cells become adherent. A similar effect has been described for PC-12 cells which exhibited accelerated adhesion in the presence of sAPPa .
Antiapoptotic effects of sAPPa
It is well established that epidermal cell death by apoptosis can be induced by extrinsic factors such as UV irradiation. Factors, which protect keratinocytes from apoptosis are of great interest as they help to understand this process and as they might be of potential significance for the development of FCS-and EGF/ BPE-free culture media. In this report we show that the UV-Binduced rates of apoptosis can be reinforced by the addition of an antibody, which binds and depletes endogenous sAPPa. These observations suggest that the lack of sAPPa favours an apoptotic pathway in keratinocytes (Fig. 7a) . However, there is a marked difference in the conditions leading to apoptosis in HaCaT cells and NHK. Whereas in HaCaT cells apoptosis is induced by moderate UV-B irradiation, NHK require additionally the depletion of endogenous sAPPa by the anti-sAPPa antibody 6E10 suggesting that NHK are more resistant against UV-B light and that this protection may be mediated by endogenous sAPPa. Accordingly, the subsequent apoptosis protection studies were performed with HaCaT cells.
The apoptosis induced by a combination of UV-B irradiation and the depletion with anti-sAPPa antibodies was complemented by a series of experiments with staurosporine which, in addition to the induction of apoptosis, inhibits PKC (Tamaoki et al., 1986) and, therefore, the a-secretase-dependent release of endogenous sAPPa (Demaerschalck et al., 1993; Skovronsky et al., 2000) . The subsequent supplementation of the culture medium with recombinant sAPPa results in a pronounced protection of HaCaT cells in that the rates of apoptosis in staurosporine-treated HaCaT cells are reduced (Fig. 7b) by about 59%. Staurosporine treatment of keratinocytes results in enhanced rates of apoptosis. This effect may be based on the staurosporine-induced inhibition of protein kinase C (PKC) and the subsequently decreased asecretase activity, resulting in lower levels of sAPPa-mediated cytoprotection. This staurosporine-induced apoptosis is significantly reduced by the addition of recombinant sAPPa. Endogenous sAPPa seems to exert a basal cytoprotection that can be enforced by the addition of recombinant sAPPa.
